Liang Lin is on the board of Shenyang Xingqi Pharmaceutical Co., Ltd., CanSino Biologics, Inc., Sansure Biotech, Inc. and Dizal (Jiangsu) Pharmaceutical Co., Ltd.
He received an undergraduate degree and a graduate degree from China Pharmaceutical University and an MBA from China Europe International Business School.
|